Patients with high-risk advanced ovarian cancer obtained a marginal survival benefit with the addition of bevacizumab ...

The FDA granted accelerated approval to the combination of avutometinib and defactinib (Avmapki Fakzynja Co-pack) for the ...

The U.S. Food and Drug Administration has approved Verastem's combination therapy for patients with a rare type of ovarian ...

For ovarian cysts that cause pain, medications such as acetaminophen, ibuprofen, or another non-steroidal anti-inflammatory ...

In line with previous clinical trial findings, real-world data show that bevacizumab improves outcomes in patients with ...

Ovarian cancer remains the leading cause of death among cancers affecting the female reproductive system, largely because ...

The U.S. Federal Drug Administration (FDA) has granted Incyclix Bio Fast Track designation for INX-315 to treat ...

A panelist discusses how antibody-drug conjugates like mirvetuximab should be sequenced in platinum-resistant ovarian cancer, ...

A real-world study based on information from an electronic health records–derived database reveals limited benefits of adding ...

The seventh warning indicator of poor ovary health or ovarian cancer is a visible change in the bowel movement. Studies have ...

World Ovarian Cancer Day, observed on May 8, highlights this deadly cancer affecting women globally. Often difficult to ...

Ovarian cancer’s lack of early symptoms makes it a difficult disease to catch in its initial stages, but by understanding the ...